X

Health Care

ACADIA Pharmaceuticals Q2 results beat estimates, raises outlook

ACADIA Pharmaceuticals (NASDAQ: ACAD) stock soared 5% in the after-market trading hours as the biopharma firm reported better-than-expected Q2 results.…

Amarin’s stock gains on Q2 results beat

Amarin Corporation plc (NASDAQ: AMRN) reported better-than-expected revenue and earnings for the second quarter of 2019, allowing the stock to…

BioTelemetry Q2 earnings exceed estimates on record revenues; stock up 10%

Medical technology company BioTelemetry, Inc. (NASDAQ: BEAT) reported higher earnings and revenues for the June quarter. Earnings topped expectations, while…

Gilead’s Q2 results beat estimates

Gilead Sciences Inc. (NYSE: GILD) beat market estimates for revenue and earnings in the second quarter of 2019. Shares were…

Amgen beats Q2 earnings and revenue estimates

Amgen Inc. (NASDAQ: AMGN) reported second quarter 2019 adjusted EPS of $3.97 on revenue of $5.9 billion. Analysts had predicted…

Pfizer’s stock suffers as Q2 results and Mylan deal fail to impress Wall Street

Pfizer Inc.’s (NYSE: PFE) shares continue to trade in red after the company narrowly missed revenue estimates for the second…

Celgene Q2 profit beats estimates, lifts FY19 guidance

Celgene Corporation (NASDAQ: CELG) reported a 50% jump in earnings for the second quarter of 2019 helped by higher revenue…

Merck rises on oncology strength post Q2 earnings

Shares of pharmaceutical giant Merck (NYSE: MRK) rose 3% before the market hours on Tuesday after the company reported second-quarter…

Eli Lilly Q2 profit beats estimates, lifts FY19 forecast

Eli Lilly and Company (NYSE: LLY) swung to a profit in the second quarter of 2019 from a loss last…

Illumina’s Q2 results beat market estimates

Illumina Inc. (NASDAQ: ILMN) beat analysts’ forecasts for revenue and earnings in the second quarter of 2019. Despite the beat,…